Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    Open Studies | caffeine
Show Display Options
Rank Status Study
21 Recruiting Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents
Condition: Pediatric Obesity
Interventions: Drug: Caffeine 100mg / Albuterol 4mg;   Drug: Placebo;   Radiation: DXA scan for body composition;   Behavioral: Family weight management counseling;   Behavioral: Visual Analog Scale for hunger and satiety
22 Not yet recruiting The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Nonalcoholic Fatty Liver
Interventions: Dietary Supplement: caffeine and chlorogenic acid;   Dietary Supplement: caffeine;   Dietary Supplement: chlorogenic acid;   Dietary Supplement: placebo
23 Recruiting The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
Condition: Retinopathy of Prematurity
Interventions: Drug: Caffeine citrate;   Drug: Ibuprofen;   Drug: Ketorolac
24 Not yet recruiting The Effects of SPRINT, a Combination of Natural Ingredients, on Cognition in Healthy Young Volunteers
Condition: Biomedical Enhancement
Interventions: Dietary Supplement: SPRINT;   Dietary Supplement: Caffeine-alone;   Other: Placebo
25 Recruiting Study on Sodium and Caffeine in Children and Adolescents
Conditions: Sodium;   Caffeine
Intervention: Other: No intervention
26 Recruiting How Does Altering the Timing of Pre-exercise Low-dose Caffeine Ingestion Affect Endurance Exercise Performance
Condition: Healthy
Interventions: Other: Caffeine powder -60;   Other: Caffeine powder -30;   Other: Caffeine powder 0;   Other: Placebo powder -60;   Other: Placebo powder -30;   Other: Placebo powder 0
27 Not yet recruiting Management of Apnea in Late Preterm and Term Infants
Condition: Apnea
Interventions: Drug: Caffeine citrate;   Device: Home monitor;   Other: Continued inpatient monitoring until apnea resolution
28 Recruiting Oxygen Saturation and Caffeine Post-Discharge
Condition: Prematurity
Intervention: Other: Pulse oxymeter measurements
29 Recruiting Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain
Condition: Pain
Interventions: Drug: Paracetamol and caffeine;   Drug: Paracetamol;   Other: Placebo
30 Recruiting Influence of Lifestyle Factors on Neutrophil Migration Pilot Study
Condition: Neutrophil Chemotactic Response
Interventions: Other: Exercise;   Drug: ProLab 200mg caffeine capsule;   Other: Ethanol ingestion
31 Recruiting A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
Condition: Neoplasm Metastasis
Interventions: Drug: Drug Cocktail;   Drug: Abemaciclib
32 Recruiting Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial
Condition: C.Surgical Procedure; Digestive System
Interventions: Dietary Supplement: Caffeine;   Other: Gum;   Behavioral: wear silicone bracelet
33 Not yet recruiting Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks
Condition: Migraine Headache
Interventions: Drug: Cefaliv® & Placebo;   Drug: Neosaldina® & Placebo
34 Not yet recruiting Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
Condition: Migraine
Interventions: Drug: Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.;   Drug: Acetaminophen
35 Recruiting Pharmacokinetic Drug-Drug Interaction Study of Rucaparib
Condition: Neoplasms
Interventions: Drug: Caffeine;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam;   Drug: digoxin;   Drug: Vitamin K;   Drug: Rucaparib
36 Recruiting Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects
Condition: Sickle Cell Disease
Intervention: Drug: GBT440
37 Recruiting Comparison of Two Flow Rates of HHHFNC to Prevent Extubation Failure in Preterm Infants
Condition: Prematurity, Mechanical Ventilation
Interventions: Device: HHHFNC 6 liter minute;   Device: HHHFNC 3 liters/min
38 Recruiting Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke
Condition: Stroke
Intervention:
39 Recruiting This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
Condition: Psoriasis
Interventions: Drug: Caffeine;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Metoprolol;   Drug: Midazolam;   Drug: Risankizumab
40 Not yet recruiting Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke
Condition: Stroke
Intervention: Device: REVIVETM SE thrombectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.